Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.

被引：1
|
作者：
Saad, Eddy
Labaki, Chris
Miron, Benjamin
Park, Jihye
Bakouny, Ziad
Nassar, Amin
Saliby, Renee Maria
Semaan, Karl
Eid, Marc
Meli, Kevin
Laimon, Yasmin Nabil
Geynisman, Daniel M.
Kokate, Rutika
Braun, David A.
Signoretti, Sabina
Mcgregor, Bradley Alexander
Plimack, Elizabeth R.
Choueiri, Toni K.
Van Allen, Eliezer Mendel
Zibelman, Matthew R.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Fox Chase Canc Ctr, Philadelphia, PA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Yale Canc Ctr, New Haven, CT USA
[6] Harvard Univ, Cambridge, MA USA
[7] Brigham & Womens Hosp, Boston, MA USA
[8] Yale Univ, New Haven, CT USA
[9] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[10] Fox Chase Canc Ctr, Temple Hlth, Philadelphia, PA USA
[11] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-2494-9200; 3282-206-3691-5663-4986; 613-225-3248-9559-9794; 3282-206-3691-2722-5055; 3282-646-4685-2628; 5; 3; 2; 38092-18323; 38092-27449; 38092-23384;
D O I：
10.1200/JCO.2024.42.4_suppl.459
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
    Derosa, Lisa
    Routy, Bertrand
    Enot, David
    Baciarello, Giulia
    Massard, Christophe
    Loriot, Yohann
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [22] Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors
    Gul, Anita
    Stewart, Tyler F.
    Mantia, Charlene M.
    Shah, Neil J.
    Gatof, Emily Stern
    Long, Ying
    Allman, Kimberly D.
    Ornstein, Moshe C.
    Hammers, Hans J.
    McDermott, David F.
    Atkins, Michael B.
    Hurwitz, Michael
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) : 3088 - +
  • [23] Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma
    Anagnostou, Valsamo
    Bruhm, Daniel C.
    Niknafs, Noushin
    White, James R.
    Shao, Xiaoshan M.
    Sidhom, John William
    Stein, Julie
    Tsai, Hua-Ling
    Wang, Hao
    Belcaid, Zineb
    Murray, Joseph
    Balan, Archana
    Ferreira, Leonardo
    Ross-Macdonald, Petra
    Wind-Rotolo, Megan
    Baras, Alexander S.
    Taube, Janis
    Karchin, Rachel
    Scharpf, Robert B.
    Grasso, Catherine
    Ribas, Antoni
    Pardoll, Drew M.
    Topalian, Suzanne L.
    Velculescu, Victor E.
    CELL REPORTS MEDICINE, 2020, 1 (08)
  • [24] Checkpoint inhibitors in metastatic papillary renal cell carcinoma
    de Vries-Brilland, M.
    McDermott, D. F.
    Suarez, C.
    Powles, T.
    Gross-Goupil, M.
    Ravaud, A.
    Flippot, R.
    Escudier, B.
    Albiges, L.
    CANCER TREATMENT REVIEWS, 2021, 99
  • [25] Biological Biomarkers of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Masson, Claire
    Thouvenin, Jonathan
    Boudier, Philippe
    Maillet, Denis
    Kuchler-Bopp, Sabine
    Barthelemy, Philippe
    Massfelder, Thierry
    CANCERS, 2023, 15 (12)
  • [26] Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors
    Negishi, Takahito
    Nakagawa, Tohru
    Nishiyama, Naotaka
    Kitamura, Hiroshi
    Okajima, Eijiro
    Furubayashi, Nobuki
    Hori, Yoshifumi
    Kuroiwa, Kentarou
    Son, Yuhyon
    Seki, Narihito
    Tomoda, Toshihisa
    Nakamura, Motonobu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (12) : 1430 - 1435
  • [27] Liver injury by immune checkpoint inhibitors in patients with hepatocellular carcinoma.
    Personeni, Nicola
    Pressiani, Tiziana
    Capogreco, Antonio
    Dal Buono, Arianna
    D'Alessio, Antonio
    Prete, Maria Giuseppina
    Smiroldo, Valeria
    Bozzarelli, Silvia
    Giordano, Laura
    Aghemo, Alessio
    Santoro, Armando
    Rimassa, Lorenza
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [28] Immune Resistance Interrogation Study (IRIS): A prospective comprehensive multi-omic analysis in patients with intrinsic and acquired resistance to immunotherapy.
    Genta, Sofia
    Tsao, Ming Sound
    Wang, Ben X.
    Hansen, Aaron Richard
    Pugh, Trevor John
    Lupien, Mathieu
    Coburn, Bryan
    Diaz-Mejia, Javier
    Butler, Marcus O.
    Bedard, Philippe L.
    Razak, Albiruni Ryan Abdul
    Hakgor, Sevan
    Speers, Vanessa
    Wagner, Heidi
    Tamblyn, Laura
    Ketela, Troy
    Torti, Dax
    Radulovich, Nikolina
    Siu, Lillian L.
    Spreafico, Anna
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Chehade, Razane El Hajj
    Semaan, Karl
    Saliby, Renee Maria
    Saad, Eddy
    Nawfal, Rashad
    Machaalani, Marc
    Eid, Marc
    Yekeduz, Emre
    Steiner, Clara
    Sun, Maxine
    Kaymakcalan, Marina
    Choueiri, Toni K.
    ONCOLOGIST, 2024, 29
  • [30] Characterization of the immune cell profile in metastatic nasopharyngeal carcinoma treated with chemotherapy and immune checkpoint inhibitors
    Kuo, Yung-Chia
    Tai, Tzong-Shyuan
    Yang, Huang-Yu
    Lui, Kar-Wai
    Chao, Yin-Kai
    Lee, Li-Yu
    Huang, Yenlin
    Fan, Hsien-Chi
    Lin, An-Chi
    Hsieh, Chia-Hsun
    Yang, Zhangung
    Chang, Kai-Ping
    Lin, Chien-Yu
    Wang, Hung-Ming
    Hsu, Cheng-Lung
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (12):
12345